ERBB2 and breast carcinoma: We next studied the expression of galectins at the protein level by immunohistochemistry (IHC) using tissue microarrays (TMAs) constructed from 213 human breast cancer tumor tissues representative of each molecular subtypes of breast cancer defined based on ER/PR/HER2 status and with clinical data.